- Home
- / Pyridam Farma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pyridam Farma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
RP702.1 B
FY, 2023
CreditSafe Score
?
Score changed on Jun 15, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| IDR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|
| Revenue | 250.4B | 247.1B | 277.4B | 630.5B | 715.4B | 702.1B |
| Cost of goods sold | 92.2B | 94.5B | 107.2B | 363.0B | 408.4B | 362.6B |
| Gross profit | 158.7B | 155.9B | 172.0B | 294.0B | 688.0B | 349.0B |
| Gross profit margin, % | 63.1% | 62.0% | 46.6% | 96.2% | 49.7% | |
| Operating expense total | 136.9B | 132.8B | 129.5B | 202.4B | 263.9B | 274.9B |
| Depreciation and amortization | 7.3B | 7.4B | 8.4B | 31.5B | 71.3B | 57.4B |
| EBITDA | 21.8B | 23.2B | 42.6B | 91.7B | 424.2B | 74.1B |
| EBITDA margin, % | 9.4% | 15.3% | 14.5% | 59.3% | 10.6% | |
| EBIT | 15.5B | 16.8B | 34.7B | 60.8B | 353.6B | 16.7B |
| EBIT margin, % | 6.8% | 12.5% | 9.6% | 49.4% | 2.4% | |
| Interest income | 14.3M | 23.3M | 63.4M | 299.2M | 4.3B | |
| Interest expense | 3.2B | 2.8B | 2.6B | 43.4B | 87.1B | 86.5B |
| Pre tax profit | 11.3B | 12.5B | 29.6B | 8.8B | 263.1B | (83.2B) |
| Income tax expense | 2.9B | 3.2B | 7.5B | 3.3B | (12.4B) | 2.0B |
| Net Income | 8.4B | 9.3B | 22.1B | 5.5B | 275.5B | (85.2B) |